Meiyang Xi

Shaoxing, 312000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Biomacromolecule-mediated targeted protein degradation: an emerging strategy for cancer therapy.

Biomacromolecule-mediated targeted protein degradation: an emerging strategy for cancer therapy.

Journal: European journal of medicinal chemistry

Published: May 20, 2025

Identification of Potent Leucine-Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation.

Identification of Potent Leucine-Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation.

Journal: Chemical biology & drug design

Published: November 23, 2024

Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads.

Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads.

Journal: European journal of medicinal chemistry

Published: July 12, 2024

Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson's disease.

Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson's disease.

Journal: Bioorganic chemistry

Published: August 17, 2023

Hyaluronic Acid Poly(glyceryl)10-Stearate Derivatives: Novel Emulsifiers for Improving the Gastrointestinal Stability and Bioaccessibility of Coenzyme Q10 Nanoemulsions.

Hyaluronic Acid Poly(glyceryl)10-Stearate Derivatives: Novel Emulsifiers for Improving the Gastrointestinal Stability and Bioaccessibility of Coenzyme Q10 Nanoemulsions.

Journal: Journal of agricultural and food chemistry

Published: July 12, 2023

Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases.

Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases.

Journal: European journal of medicinal chemistry

Published: January 25, 2023

Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement.

Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement.

Journal: Bioorganic chemistry

Published: July 27, 2022

Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.

Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.

Journal: European journal of medicinal chemistry

Published: December 07, 2021

Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors.

Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: November 30, 2021

Therapeutic potential of targeting SHP2 in human developmental disorders and cancers.

Therapeutic potential of targeting SHP2 in human developmental disorders and cancers.

Journal: European journal of medicinal chemistry

Published: December 09, 2019

Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.

Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.

Journal: European journal of medicinal chemistry

Published: March 21, 2019

CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.

CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.

Journal: European journal of medicinal chemistry

Published: October 24, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026